Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,361,824 papers from all fields of science
Search
Sign In
Create Free Account
Inducible T-Cell Co-Stimulator Protein
Known as:
CD278 Antigen
, Co-Stimulator, Inducible T-Cell
, Activation Inducible Lymphocyte Immunomediatory Molecule
Expand
A costimulatory receptor that is specific for INDUCIBLE T-CELL CO-STIMULATOR LIGAND. The receptor is associated with a diverse array of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (1)
ICOS protein, human
In Blood
agonists
antagonists & inhibitors
aspects of radiation effects
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Trastornos de la marcha en la Enfermedad de Parkinson: aspectos clín icos, fisiopatológicos y terapéuticos
Tahimí Cardoso Suárez
,
Carmen Lucila Álvarez González
,
A. D. L. Fe
,
C. Alonso
,
Hanoi Sabater Hernández
,
L. A. González
2017
Corpus ID: 188748720
Introduccion : Los trastornos de la marcha en pacientes con Enfermedad de Parkinson (EP) son de dificil manejo y repercuten…
Expand
2014
2014
Μελέτη των γονιδίων και των πρωτεϊνών TACI και ICOS σε ασθενείς με λεμφοπαραγωγά σύνδρομα
Antigoni Mamara
,
Αντιγόνη Μαμάρα
2014
Corpus ID: 196167006
2011
2011
Incidencia de la formulación en las propiedades de adhesivos termofusibles en base EVA que contienen resinas de hidrocarburo y ceras de diferente naturaleza
Alejandro Ramírez Guillem
2011
Corpus ID: 170827900
Los adhesivos termofusibles son solidos termoplasticos a temperatura ambiente y liquidos cuando se aplican. Una vez fundidos, se…
Expand
2011
2011
Ardudrop 1.2: nuevos sensores y mejoras en la electrónica del dispositivo
M. Hernández
2011
Corpus ID: 159573469
El dispositivo ArduDrop ha sido desarrollado para el estudio de la humedad del suelo y su relacion con parametros ambientales. En…
Expand
2010
2010
ARQUITECTURA Y URBANISMO BIOCLIMATICO: PRESENTE Y FUTURO PARA EL HABITAT DEL HOMBRE CONTEMPORANEO
P. Trujillo
,
R. Lopez
,
Hernando Parra Lara
2010
Corpus ID: 131194640
Desde tiempos inmemoriales el hombre busco refugiarse de los agentes climaticos y tambien organizar el espacio vital segun sus…
Expand
2006
2006
Endothelins Induce CCR 7 Expression by Breast Tumor Cells via Endothelin Receptor A and Hypoxia-Inducible Factor-1
Julia L. Wilson
,
J. Burchell
,
M. Grimshaw
2006
Corpus ID: 40817056
Endothelin expression is increased in breast tumors and is associated with invasion and metastasis, whereas CCR7 expression by…
Expand
2006
2006
oneurôniodifusopropostoporKwan Caiobtiveramo smelhoresíndicesdeacertos dosistema. Osresultadosforamanalisadosconsider andoosindicadores quantitativosdemodelagem.Aáreadedomínio,util…
Neuro Difusos
,
Kwan Caihasobtainedthehighestratesofsystemh
2006
Corpus ID: 183956089
Thispaperproposesalearningmethodolog ywhichprovidesaunified� frameworkforintegratingthecomputationalparalle…
Expand
2005
2005
Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Carole Guillonneau
,
V. Aubry
,
+4 authors
I. Anegon
Transplantation
2005
Corpus ID: 26116420
BACKGROUND : Blockade of the CD40-CD40L pathway results in long-term allograft survival but does not prevent chronic rejection…
Expand
2004
2004
Entwicklung und Charakterisierung von zellulären B7 Vakzinen sowie Analyse und Manipulation ihrer Wechselwirkung mit T-Zellen
K. Kronfeld
2004
Corpus ID: 191339014
In dieser Arbeit konnte das Potential der T-Zell Aktivierung durch B7-1 bzw. B7-2 exprimie-rende Nierenkarzinomzellen gezeigt…
Expand
2003
2003
Reuniões técnicas sobre couros e peles.
A. B. Sancevero
2003
Corpus ID: 149121807
• Implementação de pesquisa e desenvolvimento, adaptação, otimização e difusão de tecnologias para a cadeia produtiva do couro…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE